Clinical Trials Browser

OTHER × Hormone Refractory Prostate Cancer × cabazitaxel × Clear all

NCT01518283 2017-07-02

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

Phase 2 Completed

Hormone Refractory Prostate Cancer